Related Experiment Video
Updated: Jul 1, 2025

Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
Digital Ischemia in an Extreme Preterm Infant Treated with Nitroglycerin Patch
Mansour Al Qurashi1,2, Abdulaziz Al-Khotani3,4, Farzeen Mohtisham1,2
1Department of Pediatrics, Ministry of National Guard Health Affairs (MNGHA), King Saud Bin Abdul Aziz University for Health Sciences (KSAU-HS), WR King Abdulaziz Medical City, Jeddah, Saudi Arabia.
Neonatal ischemic limb lesions can occur in intensive care units. Topical nitroglycerine shows promise for treating digital ischemia in preterm infants, as seen in a recent case study.
Area of Science:
- Neonatology
- Pediatric vascular medicine
- Pharmacology
Background:
- Ischemic limb lesions are a known complication in neonatal intensive care units.
- Risk factors include arterial catheters, blood sampling, and vasoactive medications.
- Management of peripheral tissue ischemia in extreme preterm infants lacks a standardized approach.
Observation:
- A case of digital ischemia in an extreme preterm infant is presented.
- The infant had no clear risk factors beyond extreme prematurity.
- The ischemia resolved following topical nitroglycerine therapy.
Findings:
- Topical nitroglycerine effectively treated digital ischemia in an extreme preterm infant.
- This case suggests a potential therapeutic option for similar neonatal conditions.
- Early detection and intervention are crucial for managing neonatal peripheral tissue ischemia.
Implications:
- Topical nitroglycerine may be a viable treatment for neonatal peripheral tissue ischemia.
- Further research is warranted to establish standardized treatment protocols.
- This approach could improve outcomes for preterm infants suffering from ischemic complications.
Related Concept Videos
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Antihypertensive Drugs: Vasodilators
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

